Diagnostic biomarkers for obsessive-compulsive disorder: A reasonable quest or ignis fatuus?
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 118, 504-513
Abstract
No abstract availableKeywords
Funding Information
- Generalitat de Catalunya
- Departament d'Empresa i Coneixement, Generalitat de Catalunya
- Fundación Alicia Koplowitz
- Instituto de Salud Carlos III
This publication has 65 references indexed in Scilit:
- The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy researchClinical Psychology Review, 2013
- Meta-Analysis of Oxidative Stress in SchizophreniaBiological Psychiatry, 2013
- A way forward for research on biomarkers for psychiatric disordersJournal of Psychiatry and Neuroscience, 2013
- Brain-Derived Neurotrophic Factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysisFrontiers in Integrative Neuroscience, 2013
- What kinds of things are psychiatric disorders?Psychological Medicine, 2010
- Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analysesCanadian Medical Association Journal, 2009
- Children with obsessive-compulsive disorder: are they just “little adults”?Journal of Clinical Investigation, 2009
- Uncertainty in heterogeneity estimates in meta-analysesBMJ, 2007
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986